SAENGER BRADLEY 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 29, 2024
Insider Transaction Report
Form 4
SAENGER BRADLEY
Chief Financial Officer
Transactions
- Award
Stock Option
2024-02-27+282,000→ 282,000 totalExercise: $0.46From: 2025-02-27Exp: 2034-02-27→ Common Stock (282,000 underlying) - Award
Stock Option
2024-02-27+282,000→ 282,000 totalExercise: $0.37From: 2025-02-27Exp: 2034-02-27→ Common Stock (282,000 underlying)
Footnotes (2)
- [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.